|
The approved ANDA is a generic version of Sinequan by Pfizer. The drug is indicated for the treatment of anxiety, depression, and other target symptoms of psychoneurosis.
The capsules will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat.
According to IQVIA MAT June 2023, Doxepin Hydrochloride capsules had estimated annual sales of $23.90 million in the United States.
JB Pharma is one of the fastest growing pharmaceutical companies in India and a leading player in the hypertension segment. Besides its strong India presence, which accounts for majority of its revenue, its other two home markets are Russia and South Africa. The company exports its finished formulations to over 40 countries including the USA. Besides supplying branded generic formulations to several countries, it is also a leader in the manufacturing of medicated lozenges.
The company's consolidated net profit jumped 35.5% to Rs 142.32 crore on 14.2% rise in net sales to Rs 896.20 crore in Q1 FY24 over Q1 FY23.
|